R 540 (Carbidopa and levodopa 25 mg / 250 mg)
Pill imprint R 540 has been identified as Carbidopa and levodopa 25 mg / 250 mg.
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for R 540 (Carbidopa and levodopa 25 mg / 250 mg)
- 25 mg / 250 mg
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|68084-0094||Amerisource Health Services|
|54868-2834||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about carbidopa/levodopa
- Carbidopa/levodopa orally disintegrating tablets
- Carbidopa/levodopa sustained-release tablets
- Carbidopa and levodopa